Tag: Inogen

GOLETA, Calif. – Demand is high, but with supply restricted, Inogen is prioritizing POC orders from its direct-to-consumer channel.  That meant it was unable to fulfill some orders from other channels, particularly its domestic business-to-business channel, which saw sales of $22.8 million in the third quarter, down 1.1% from the same period last year.  "Due to supply chain constraints and in an effort to optimize financial results, we intentionally focused our available capacity...

GOLETA, Calif. – Inogen reported $93.1 million in total revenue for the third quarter of 2021, up 25.3% from the same period last year.  By business segment, it reported $36.3 million in revenue for domestic direct-to-consumer sales, up 24.6%; and $12.1 million for rentals, up 61.3%.  “I continue to be pleased with the sustained demand we are seeing for our market-leading portable oxygen concentrators, in spite of the challenging supply chain environment,” said Nabil...

GOLETA, Calif. – Inogen reported $93.1 million in total revenue for the third quarter of 2021, up 25.3% from the same period last year.  By business segment, it reported $36.3 million in revenue for domestic direct-to-consumer sales, up 24.6%; and $12.1 million for rentals, up 61.3%.  “I continue to be pleased with the sustained demand we are seeing for our market-leading portable oxygen concentrators, in spite of the challenging supply chain environment,” said Nabil...

GOLETA, Calif. – Inogen has named Stanislav Glezer, M.D., to the role of CTO responsible for R&D and engineering, medical affairs and regulatory affairs. Glezer, who joined Inogen in June, will remain an executive vice president of the company. He has more than 27 years of experience and has held leadership roles at a variety of medical technology and biotechnology firms, including Becton, Dickinson and Company, Adocia S.A., Novo Nordisk, Inc., and Sanofi S.A. “Since joining Inogen...

GOLETA, Cailf. – Inogen has announced an agreement with Ashfield Healthcare to enhance its go-to-market capabilities.  Per the agreement, Ashfield will add about 20 dedicated sales representatives to Inogen’s prescriber sales organization and provide the company access to its proprietary insights and data, including the specialized health care intelligence platform Gravity.ai, to support growth and drive performance in the clinician sales channel.  “Forming this...

GOLETA, Cailf. – Inogen saw a nice boost in revenue in the second quarter, thanks to increasing consumer confidence and ambulation, but the company expects supply chain constraints to inhibit its ability to meet demand in the second half of 2021.  The company expects total revenue for the second half to be lower than the first half of the year, and it expects net losses for the third and fourth quarters, as well as for the full year.  “We continue to see strong consumer...

GOLETA, Calif. – Inogen reported total revenue of $101.6 million for the second quarter of 2021, a 41.7% increase compared to the same period in 2020, primarily due to strong consumer demand, improved average selling prices in all channels and reduced COVID-19 pandemic-related impacts. The company reported domestic direct-to-consumer revenue of $40.9 million, a 35.6% increase. Rental revenue was $11.3 million, an 85.2% increase. “We saw strong revenue growth of 41.7% as compared...

GOLETA, Calif. – Inogen’s board of directors has appointed Jason Somer as executive vice president and general counsel and secretary, effective July 12. “On behalf of the board, I would like to congratulate Jason on this appointment as I believe that he will be a tremendous asset to Inogen and a great addition to our executive team,” said Nabil Shabshab, CEO. “I believe Jason’s 25 years of experience in general counsel and attorney roles will be a great enabler...

NORTHFIELD, Ill. – Medline Industries has entered into an agreement to receive a majority investment from a group of private equity firms, including Blackstone, Carlyle Group and Hellman & Friedman, worth a reported $30-plus billion.  Medline, which generated revenues of $17.5 billion in 2020, will use the new resources from the partnership to expand its product offerings, accelerate international expansion and continue to make new infrastructure investments to strengthen its global...

Inogen has appointed Dr. Stanislav Glezer as executive vice president and chief medical officer. Glezer has more than 25 years of experience in clinical research and medical affair roles, most recently at Becton, Dickinson and Company as worldwide vice president of medical affairs for Diabetes Care.  “I look forward to contributing to the next phase of Inogen’s planned growth as we continue to seek ways to design patient centric outcomes studies to improve access to our best-in-class...